로라제팜 (Korean Wikipedia)

Analysis of information sources in references of the Wikipedia article "로라제팜" in Korean language version.

refsWebsite

Global rank Korean rank

35nih.gov

4^th place

16doi.org

2^nd place

3^rd place

7web.archive.org

1^st place

2benzo.org.uk

low place

8,177^th place

1wiley.com

222^nd place

164^th place

1ccmjournal.com

low place

1sciencedirect.com

149^th place

122^nd place

1nytimes.com

7^th place

36^th place

1chestjournal.org

low place

1rcpsych.org

low place

5,609^th place

1oxfordjournals.org

1,389^th place

550^th place

1baxter.com

low place

1medsafe.govt.nz

low place

1rxlist.com

7,927^th place

3,641^st place

1medscape.com

719^th place

424^th place

1nature.com

234^th place

148^th place

1independent.co.uk

36^th place

175^th place

1bmj.com

1,226^th place

829^th place

1patient.co.uk

low place

2,316^th place

baxter.com

“baxter.com - Lorazepam Injection Data Sheet” (PDF). 2007년 5월 7일에 원본 문서 (PDF)에서 보존된 문서. 2007년 5월 9일에 확인함.

benzo.org.uk

Hindmarch, Ian (1997년 1월 30일). “Benzodiazepines and their effects”. benzo.org.uk. 2007년 5월 13일에 확인함.
Genus Pharmaceuticals (1998년 1월 21일). “Lorazepam: Patient Information Leaflet, UK, 1998”. benzo.org.uk. 2007년 5월 14일에 확인함.

bmj.com

http://www.bmj.com/content/349/bmj.g5205

ccmjournal.com

Greenblatt DJ; von Moltke LL; Ehrenberg BL; Harmatz JS; Corbett KE; Wallace DW; Shader RI (2000). “Kinetics and dynamics of lorazepam during and after continuous intravenous infusion”. 《Crit Care Med》 28 (8): 2750–2757. doi:10.1097/00003246-200008000-00011. PMID 10966246.

chestjournal.org

Maltais F, Laberge F, Laviolette M (1996). "A randomized, double-blind, placebo-controlled study of lorazepam as premedication for bronchoscopy". Archived 2008년 4월 7일 - 웨이백 머신 Chest 109 (5): 1195–8. PMID 8625666.

doi.org

dx.doi.org

Greenblatt DJ; Shader RI; Franke K; Maclaughlin DS; Harmatz JS; Allen MD; Werner A; Woo E (1991). “Pharmacokinetics and bioavailability of intravenous, intramuscular, and oral lorazepam in humans”. 《J Pharm Sci》 68 (1): 57–63. doi:10.1002/jps.2600680119. PMID 31453. ^{[깨진 링크(과거 내용 찾기)]}
Greenblatt DJ; von Moltke LL; Ehrenberg BL; Harmatz JS; Corbett KE; Wallace DW; Shader RI (2000). “Kinetics and dynamics of lorazepam during and after continuous intravenous infusion”. 《Crit Care Med》 28 (8): 2750–2757. doi:10.1097/00003246-200008000-00011. PMID 10966246.
Papini O; da Cunha SP; da Silva Mathes Ado C; Bertucci C; Moisés EC; de Barros Duarte L; de Carvalho Cavalli R; Lanchote VL (2006). “Kinetic disposition of lorazepam with a focus on the glucuronidation capacity, transplacental transfer in parturients and racemization in biological samples” (PDF). 《J Pharm Biomed Anal》 40 (2): 397–403. doi:10.1016/j.jpba.2005.07.021. PMID 16143486. 2011년 3월 10일에 원본 문서 (PDF)에서 보존된 문서. 2021년 12월 22일에 확인함.
Heisterkamp DV; Cohen PJ (1975). “The effect of intravenous premedication with lorazepam (Ativan), pentobarbitone or diazepam on recall”. 《Br J Anaesth》 47 (1): 79–81. doi:10.1093/bja/47.1.79. PMID 238548.
Milligan DW; Howard MR; Judd A (1987). “Premedication with lorazepam before bone marrow biopsy”. 《J Clin Pathol》 40 (6): 696–8. doi:10.1136/jcp.40.6.696. PMID 3611398.
McAllister-Williams RH (2005). “Intramuscular haloperidol-promethazine sedates violent or agitated patients more quickly than intramuscular lorazepam”. 《Evidence-Based Mental Health》 8 (1): 7. doi:10.1136/ebmh.8.1.7. PMID 15671498.
Rosebush PI; Mazurek MF (1996). “Catatonia after benzodiazepine withdrawal”. 《Journal of clinical psychopharmacology》 16 (4): 315–9. doi:10.1097/00004714-199608000-00007. PMID 8835707.
Herrstedt J, Aapro MS, Roila F, Kataja VV (2005). "ESMO Minimum Clinical Recommendations for prophylaxis of chemotherapy-induced nausea and vomiting (NV)". Ann Oncol 16 Suppl 1: i77–9. PMID 15888767. doi 10.1093/annonc/mdi805
Yaucher NE; Fish JT; Smith HW; Wells JA (2003). “Propylene glycol-associated renal toxicity from lorazepam infusion”. 《Pharmacotherapy》 23 (9): 1094–9. doi:10.1592/phco.23.10.1094.32762. PMID 14524641.
Bond A; Lader M (1988). “Differential effects of oxazepam and lorazepam on aggressive responding”. 《Psychopharmacology (Berl.)》 95 (3): 369–73. doi:10.1007/BF00181949. PMID 3137624.
Pietras CJ; Lieving LM; Cherek DR; Lane SD; Tcheremissine OV; Nouvion S (2005). “Acute effects of lorazepam on laboratory measures of aggressive and escape responses of adult male parolees”. 《Behav Pharmacol》 16 (4): 243–51. doi:10.1097/01.fbp.0000170910.53415.77. PMID 15961964.
Kalachnik JE; Hanzel TE; Sevenich R; Harder SR (2002). “Benzodiazepine behavioral side effects: review and implications for individuals with mental retardation”. 《Am J Ment Retard》 107 (5): 376–410. doi:10.1352/0895-8017(2002)107<0376:BBSERA>2.0.CO;2. PMID 12186578.
Mancuso CE; Tanzi MG; Gabay M (2004). “Paradoxical reactions to benzodiazepines: literature review and treatment options”. 《Pharmacotherapy》 24 (9): 1177–85. doi:10.1592/phco.24.13.1177.38089. PMID 15460178. Free full text with registration
zaute M; Bacon E (2005). “Specific effects of an amnesic drug: effect of lorazepam on study time allocation and on judgment of learning”. 《Neuropsychopharmacology》 30 (1): 196–204. doi:10.1038/sj.npp.1300564. PMID 15483562. Free full text
Matthew E; Andreason P; Pettigrew K; 외. (1995). “Benzodiazepine receptors mediate regional blood flow changes in the living human brain”. 《Proc. Natl. Acad. Sci. U.S.A.》 92 (7): 2775–9. doi:10.1073/pnas.92.7.2775. PMID 7708722.
Sybirska E; Seibyl JP; Bremner JD; 외. (1993). “[123I]iomazenil SPECT imaging demonstrates significant benzodiazepine receptor reserve in human and nonhuman primate brain”. 《Neuropharmacology》 32 (7): 671–80. doi:10.1016/0028-3908(93)90080-M. PMID 8395663.

independent.co.uk

http://www.independent.co.uk/life-style/health-and-families/health-news/drugs-linked-to-brain-damage-30-years-ago-2127504.html

medsafe.govt.nz

“Lorzem Data Sheet”. New Zealand Medicines and Medical Devices Safety Authority. 1999년 6월 4일. 2007년 9월 28일에 원본 문서에서 보존된 문서. 2007년 5월 13일에 확인함.

medscape.com

Mancuso CE; Tanzi MG; Gabay M (2004). “Paradoxical reactions to benzodiazepines: literature review and treatment options”. 《Pharmacotherapy》 24 (9): 1177–85. doi:10.1592/phco.24.13.1177.38089. PMID 15460178. Free full text with registration

nature.com

zaute M; Bacon E (2005). “Specific effects of an amnesic drug: effect of lorazepam on study time allocation and on judgment of learning”. 《Neuropsychopharmacology》 30 (1): 196–204. doi:10.1038/sj.npp.1300564. PMID 15483562. Free full text

nih.gov

ncbi.nlm.nih.gov

Greenblatt DJ; Shader RI; Franke K; Maclaughlin DS; Harmatz JS; Allen MD; Werner A; Woo E (1991). “Pharmacokinetics and bioavailability of intravenous, intramuscular, and oral lorazepam in humans”. 《J Pharm Sci》 68 (1): 57–63. doi:10.1002/jps.2600680119. PMID 31453. ^{[깨진 링크(과거 내용 찾기)]}
Greenblatt DJ; von Moltke LL; Ehrenberg BL; Harmatz JS; Corbett KE; Wallace DW; Shader RI (2000). “Kinetics and dynamics of lorazepam during and after continuous intravenous infusion”. 《Crit Care Med》 28 (8): 2750–2757. doi:10.1097/00003246-200008000-00011. PMID 10966246.
Papini O; da Cunha SP; da Silva Mathes Ado C; Bertucci C; Moisés EC; de Barros Duarte L; de Carvalho Cavalli R; Lanchote VL (2006). “Kinetic disposition of lorazepam with a focus on the glucuronidation capacity, transplacental transfer in parturients and racemization in biological samples” (PDF). 《J Pharm Biomed Anal》 40 (2): 397–403. doi:10.1016/j.jpba.2005.07.021. PMID 16143486. 2011년 3월 10일에 원본 문서 (PDF)에서 보존된 문서. 2021년 12월 22일에 확인함.
Kemper N; Poser W; Poser S. (1980년 12월 5일). “[Benzodiazepine dependence: addiction potential of the benzodiazepines is greater than previously assumed (author's transl)]”. 《Deutsche medizinische Wochenschrift (1980).》 105 (49): 1707–12. PMID 7439058.
Lader M (1984). “Short-term versus long-term benzodiazepine therapy”. 《Current Med Res Opin》. 8 Suppl 4: 120–6. PMID 6144459.
Scharf MB; Kales A; Bixler EO; Jacoby JA; Schweitzer PK (1982년 2월). “Lorazepam-efficacy, side effects, and rebound phenomena”. 《Clin Pharmacol Ther》 31 (2): 175–9. PMID 6120058.
Maltais F, Laberge F, Laviolette M (1996). "A randomized, double-blind, placebo-controlled study of lorazepam as premedication for bronchoscopy". Archived 2008년 4월 7일 - 웨이백 머신 Chest 109 (5): 1195–8. PMID 8625666.
Heisterkamp DV; Cohen PJ (1975). “The effect of intravenous premedication with lorazepam (Ativan), pentobarbitone or diazepam on recall”. 《Br J Anaesth》 47 (1): 79–81. doi:10.1093/bja/47.1.79. PMID 238548.
Milligan DW; Howard MR; Judd A (1987). “Premedication with lorazepam before bone marrow biopsy”. 《J Clin Pathol》 40 (6): 696–8. doi:10.1136/jcp.40.6.696. PMID 3611398.
Isojärvi, JI; Tokola RA. (1998년 12월). “Benzodiazepines in the treatment of epilepsy in people with intellectual disability”. 《J Intellect Disabil Res.》 42 (1): 80–92. PMID 10030438.
Bird RD; Makela EH (1994). “Alcohol withdrawal: what is the benzodiazepine of choice?”. 《Ann Pharmacother》 28 (1): 67–71. PMID 8123967.
Alexander J, Tharyan P, Adams C, John T, Mol C, Philip J (2004). "Rapid tranquillisation of violent or agitated patients in a psychiatric emergency setting. Pragmatic randomised trial of intramuscular lorazepam v. haloperidol plus promethazine". Br J Psychiatry 185 (1): 63–9. PMID 15231557.
McAllister-Williams RH (2005). “Intramuscular haloperidol-promethazine sedates violent or agitated patients more quickly than intramuscular lorazepam”. 《Evidence-Based Mental Health》 8 (1): 7. doi:10.1136/ebmh.8.1.7. PMID 15671498.
Bieniek SA; Ownby RL; Penalver A; Dominguez RA (1998). “A double-blind study of lorazepam versus the combination of haloperidol and lorazepam in managing agitation”. 《Pharmacotherapy》 18 (1): 57–62. PMID 9469682.
Rosebush PI; Mazurek MF (1996). “Catatonia after benzodiazepine withdrawal”. 《Journal of clinical psychopharmacology》 16 (4): 315–9. doi:10.1097/00004714-199608000-00007. PMID 8835707.
Van Dalfsen AN; Van Den Eede F; Van Den Bossche B; Sabbe BG (2006). “[Benzodiazepines in the treatment of catatonia]”. 《Tijdschrift voor psychiatrie》 (네덜란드어) 48 (3): 235–9. PMID 16956088.
Herrstedt J, Aapro MS, Roila F, Kataja VV (2005). "ESMO Minimum Clinical Recommendations for prophylaxis of chemotherapy-induced nausea and vomiting (NV)". Ann Oncol 16 Suppl 1: i77–9. PMID 15888767. doi 10.1093/annonc/mdi805
Yaucher NE; Fish JT; Smith HW; Wells JA (2003). “Propylene glycol-associated renal toxicity from lorazepam infusion”. 《Pharmacotherapy》 23 (9): 1094–9. doi:10.1592/phco.23.10.1094.32762. PMID 14524641.
Greenblatt DJ; Schillings RT; Kyriakopoulos AA; Shader RI; Sisenwine SF; Knowles JA; Ruelius HW (1976). “Clinical pharmacokinetics of lorazepam. I. Absorption and disposition of oral 14C-lorazepam”. 《Clin Pharmacol Ther》 20 (3): 329–41. PMID 8232.
Sorel L; Mechler L; Harmant J. (1981). “Comparative trial of intravenous lorazepam and clonazepam im status epilepticus”. 《Clin Ther.》 4 (4): 326–36. PMID 6120763.
Bond A; Lader M (1988). “Differential effects of oxazepam and lorazepam on aggressive responding”. 《Psychopharmacology (Berl.)》 95 (3): 369–73. doi:10.1007/BF00181949. PMID 3137624.
Pietras CJ; Lieving LM; Cherek DR; Lane SD; Tcheremissine OV; Nouvion S (2005). “Acute effects of lorazepam on laboratory measures of aggressive and escape responses of adult male parolees”. 《Behav Pharmacol》 16 (4): 243–51. doi:10.1097/01.fbp.0000170910.53415.77. PMID 15961964.
Kalachnik JE; Hanzel TE; Sevenich R; Harder SR (2002). “Benzodiazepine behavioral side effects: review and implications for individuals with mental retardation”. 《Am J Ment Retard》 107 (5): 376–410. doi:10.1352/0895-8017(2002)107<0376:BBSERA>2.0.CO;2. PMID 12186578.
Michel L; Lang JP (2003). “[Benzodiazepines and forensic aspects]”. 《L'Encéphale》 (프랑스어) 29 (6): 479–85. PMID 15029082.
Mancuso CE; Tanzi MG; Gabay M (2004). “Paradoxical reactions to benzodiazepines: literature review and treatment options”. 《Pharmacotherapy》 24 (9): 1177–85. doi:10.1592/phco.24.13.1177.38089. PMID 15460178. Free full text with registration
Goldney RD (1977). “Paradoxical reaction to a new minor tranquilizer”. 《Med. J. Aust.》 1 (5): 139–40. PMID 15198.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2047018/
Edwards RA; Medlicott RW (1980). “Advantages and disadvantages of benzodiazepine prescription”. 《N Z Med J》 92 (671): 357–9. PMID 6109269.
zaute M; Bacon E (2005). “Specific effects of an amnesic drug: effect of lorazepam on study time allocation and on judgment of learning”. 《Neuropsychopharmacology》 30 (1): 196–204. doi:10.1038/sj.npp.1300564. PMID 15483562. Free full text
Scharf MB; Kales A; Bixler EO; Jacoby JA; Schweitzer PK (1982). “Lorazepam-efficacy, side-effects, and rebound phenomena”. 《Clin. Pharmacol. Ther.》 31 (2): 175–9. PMID 6120058.
Matthew E; Andreason P; Pettigrew K; 외. (1995). “Benzodiazepine receptors mediate regional blood flow changes in the living human brain”. 《Proc. Natl. Acad. Sci. U.S.A.》 92 (7): 2775–9. doi:10.1073/pnas.92.7.2775. PMID 7708722.
Oelschläger H. (1989년 7월 4일). “[Chemical and pharmacologic aspects of benzodiazepines]”. 《Schweiz Rundsch Med Prax.》 78 (27-28): 766–72. PMID 2570451.
Zakusov VV; Ostrovskaya RU; Kozhechkin SN; Markovich VV; Molodavkin GM; Voronina TA (1977년 10월). “Further evidence for GABA-ergic mechanisms in the action of benzodiazepines”. 《Archives internationales de pharmacodynamie et de thérapie》 229 (2): 313–26. PMID 23084.
Sybirska E; Seibyl JP; Bremner JD; 외. (1993). “[123I]iomazenil SPECT imaging demonstrates significant benzodiazepine receptor reserve in human and nonhuman primate brain”. 《Neuropharmacology》 32 (7): 671–80. doi:10.1016/0028-3908(93)90080-M. PMID 8395663.
McLean MJ; Macdonald RL. (1988년 2월). “Benzodiazepines, but not beta carbolines, limit high frequency repetitive firing of action potentials of spinal cord neurons in cell culture”. 《J Pharmacol Exp Ther.》 244 (2): 789–95. PMID 2450203.

nytimes.com

RONI CARYN RABIN, "Disparities: Study Finds Risk in Off-Label Prescribing"[1]

oxfordjournals.org

annonc.oxfordjournals.org

Herrstedt J, Aapro MS, Roila F, Kataja VV (2005). "ESMO Minimum Clinical Recommendations for prophylaxis of chemotherapy-induced nausea and vomiting (NV)". Ann Oncol 16 Suppl 1: i77–9. PMID 15888767. doi 10.1093/annonc/mdi805

patient.co.uk

“Lorazepam”. Patient UK. 2006년 10월 25일. 2007년 9월 27일에 원본 문서에서 보존된 문서. 2007년 5월 14일에 확인함.

rcpsych.org

bjp.rcpsych.org

Alexander J, Tharyan P, Adams C, John T, Mol C, Philip J (2004). "Rapid tranquillisation of violent or agitated patients in a psychiatric emergency setting. Pragmatic randomised trial of intramuscular lorazepam v. haloperidol plus promethazine". Br J Psychiatry 185 (1): 63–9. PMID 15231557.

rxlist.com

“Ativan side effects”. RxList. 2007. 2007년 8월 21일에 원본 문서에서 보존된 문서. 2007년 8월 10일에 확인함.

sciencedirect.com

Papini O; da Cunha SP; da Silva Mathes Ado C; Bertucci C; Moisés EC; de Barros Duarte L; de Carvalho Cavalli R; Lanchote VL (2006). “Kinetic disposition of lorazepam with a focus on the glucuronidation capacity, transplacental transfer in parturients and racemization in biological samples” (PDF). 《J Pharm Biomed Anal》 40 (2): 397–403. doi:10.1016/j.jpba.2005.07.021. PMID 16143486. 2011년 3월 10일에 원본 문서 (PDF)에서 보존된 문서. 2021년 12월 22일에 확인함.

web.archive.org

Greenblatt DJ; Shader RI; Franke K; Maclaughlin DS; Harmatz JS; Allen MD; Werner A; Woo E (1991). “Pharmacokinetics and bioavailability of intravenous, intramuscular, and oral lorazepam in humans”. 《J Pharm Sci》 68 (1): 57–63. doi:10.1002/jps.2600680119. PMID 31453. ^{[깨진 링크(과거 내용 찾기)]}
Papini O; da Cunha SP; da Silva Mathes Ado C; Bertucci C; Moisés EC; de Barros Duarte L; de Carvalho Cavalli R; Lanchote VL (2006). “Kinetic disposition of lorazepam with a focus on the glucuronidation capacity, transplacental transfer in parturients and racemization in biological samples” (PDF). 《J Pharm Biomed Anal》 40 (2): 397–403. doi:10.1016/j.jpba.2005.07.021. PMID 16143486. 2011년 3월 10일에 원본 문서 (PDF)에서 보존된 문서. 2021년 12월 22일에 확인함.
Maltais F, Laberge F, Laviolette M (1996). "A randomized, double-blind, placebo-controlled study of lorazepam as premedication for bronchoscopy". Archived 2008년 4월 7일 - 웨이백 머신 Chest 109 (5): 1195–8. PMID 8625666.
“baxter.com - Lorazepam Injection Data Sheet” (PDF). 2007년 5월 7일에 원본 문서 (PDF)에서 보존된 문서. 2007년 5월 9일에 확인함.
“Lorzem Data Sheet”. New Zealand Medicines and Medical Devices Safety Authority. 1999년 6월 4일. 2007년 9월 28일에 원본 문서에서 보존된 문서. 2007년 5월 13일에 확인함.
“Ativan side effects”. RxList. 2007. 2007년 8월 21일에 원본 문서에서 보존된 문서. 2007년 8월 10일에 확인함.
“Lorazepam”. Patient UK. 2006년 10월 25일. 2007년 9월 27일에 원본 문서에서 보존된 문서. 2007년 5월 14일에 확인함.

wiley.com

www3.interscience.wiley.com

Greenblatt DJ; Shader RI; Franke K; Maclaughlin DS; Harmatz JS; Allen MD; Werner A; Woo E (1991). “Pharmacokinetics and bioavailability of intravenous, intramuscular, and oral lorazepam in humans”. 《J Pharm Sci》 68 (1): 57–63. doi:10.1002/jps.2600680119. PMID 31453. ^{[깨진 링크(과거 내용 찾기)]}